Anti-CD19 CAR-modified T cells, however, do not distinguish between normal B-cells and B-CLL cells leading to the elimination of normal B-cells as well (Figure 1(f)). This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.